Steven Hepburn Vyant Bio, Inc. (VYNT) insider trading activity
Steven Hepburn is VP of Biopharma Marketing of Vyant Bio, Inc.. Currently has a direct ownership of 3,000 shares of VYNT, which is worth approximately $0. The most recent transaction as insider was on May 29, 2015, when has been sold 3,000 shares (Common Stock, par value $0.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
3K
0%
3M change
0%
12M change
Total Value Held
$0
SH
Steven Hepburn
VP of Biopharma Marketing
Rutherford, NJ